Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 74 | 59 | 61 | 58 | 47 |
| Accounts receivable | -95 | 203 | 397 | -593 | -10 |
| Other Working Capital | -170 | 243 | 1,001 | -185 | -1 |
| Other Operating Activity | -542 | -1,329 | -1,552 | -138 | -949 |
| Operating Cash Flow | $-733 | $-824 | $-92 | $-858 | $-913 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -3 | -10 | -5 | -149 |
| Purchase Sale Intangibles | -5 | -13 | -97 | -45 | -21 |
| Other Investing Activity | 0 | 0 | -20 | 0 | 0 |
| Investing Cash Flow | $-9 | $-16 | $-127 | $-50 | $-170 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,024 | 511 | 345 | 1,294 | 109 |
| Debt Repayment | -236 | -229 | -210 | -49 | -139 |
| Common Stock Issued | 974 | 340 | N/A | N/A | N/A |
| Other Financing Activity | -402 | -20 | -55 | 500 | 936 |
| Financing Cash Flow | $2,360 | $603 | $80 | $1,745 | $906 |
| Beginning Cash Position | 916 | 1,153 | 1,293 | 456 | 633 |
| End Cash Position | 2,533 | 916 | 1,153 | 1,293 | 456 |
| Net Cash Flow | $1,617 | $-237 | $-140 | $837 | $-177 |
| Free Cash Flow | |||||
| Operating Cash Flow | -733 | -824 | -92 | -858 | -913 |
| Capital Expenditure | -9 | -16 | -107 | -50 | -170 |
| Free Cash Flow | -742 | -840 | -199 | -909 | -1,083 |